Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managin...
Títulos similares
-
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
por: Claudia Crimi, et al.
Publicado: (2023-11-01) -
Economic impact of a more extensive use of FENO testing on the Italian population with asthma
por: Carla Rognoni, et al.
Publicado: (2023-06-01) -
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Paolo Solidoro, et al.
Publicado: (2022-01-01) -
Critical evaluation of asthma biomarkers in clinical practice
por: Giuseppe Guida, et al.
Publicado: (2022-10-01) -
Nasal polyps impact in severe asthma patients: evidences from the SANI
por: Giorgio Walter Canonica, et al.
Publicado: (2020-08-01)